Manulife (Manufacturers Life Insurance)’s Aegerion Pharmaceuticals AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-846
| Closed | -$3K | – | 4555 |
|
|
2016
Q3 | $3K | Hold |
846
| – | – | ﹤0.01% | 4038 |
|
|
2016
Q2 | $1K | Sell |
846
-17,010
| -95% | -$38.9K | ﹤0.01% | 4217 |
|
|
2016
Q1 | $69K | Buy |
17,856
+790
| +5% | +$4.89K | ﹤0.01% | 3203 |
|
|
2015
Q4 | $173 | Buy |
17,066
+414
| +2% | +$4.98K | ﹤0.01% | 2768 |
|
|
2015
Q3 | $226 | Buy |
16,652
+250
| +2% | +$4.45K | ﹤0.01% | 2558 |
|
|
2015
Q2 | $311 | Sell |
16,402
-3,389
| -17% | -$73.3K | ﹤0.01% | 2479 |
|
|
2015
Q1 | $518 | Buy |
19,791
+732
| +4% | +$18.6K | ﹤0.01% | 2061 |
|
|
2014
Q4 | $399 | Sell |
19,059
-105
| -0.5% | -$2.65K | ﹤0.01% | 2143 |
|
|
2014
Q3 | $640 | Buy |
19,164
+473
| +3% | +$14.7K | ﹤0.01% | 1834 |
|
|
2014
Q2 | $600K | Sell |
18,691
-3,083
| -14% | -$115K | ﹤0.01% | 1917 |
|
|
2014
Q1 | $1K | Sell |
21,774
-38
| -0.2% | -$2.23K | ﹤0.01% | 1623 |
|
|
2013
Q4 | $1.55K | Sell |
21,812
-9
| -0% | -$688 | ﹤0.01% | 1391 |
|
|
2013
Q3 | $1.87K | Sell |
21,821
-536
| -2% | -$45.4K | ﹤0.01% | 1319 |
|
|
2013
Q2 | $1.42M | Buy |
+22,357
| New | +$1.19M | ﹤0.01% | 1330 |
|
Manulife (Manufacturers Life Insurance)'s AEGR Position: Q4 2016 in Review
Manulife (Manufacturers Life Insurance) sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 846 shares — an estimated $3K sold.
Manulife (Manufacturers Life Insurance) first reported a position in AEGR in Q2 2013 and held it in 14 quarters. The position peaked at $1.42M in Q2 2013. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.
- Manulife (Manufacturers Life Insurance) reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 846 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $3K.
- Manulife (Manufacturers Life Insurance) first reported a position in Aegerion Pharmaceuticals in Q2 2013 and held it in 14 quarters.
- Manulife (Manufacturers Life Insurance)'s Aegerion Pharmaceuticals position peaked at $1.42M in Q2 2013.
- 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2016, filed 14 Feb 2017.